News brief
On 2026/6/1, LinkedIn reported that US oncology workflow automation company Triomics had raised USD 22 million in Series B funding. ARR grew 10 times year over year, but absolute revenue was undisclosed.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.linkedin.com ↗Published Jun 1, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年6月1日，据LinkedIn报道，美国肿瘤工作流自动化公司Triomics完成2200万美元B轮融资，ARR同比增长10倍但未披露绝对收入。